ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025
Evaluation of 415-nm Blue Light and Hypochlorous Acid on the Rhesus Macaque (Macaca mulatta) Cranial Implant Microbiota.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cranially-implanted macaques are a crucial model for neuroscience research. Implant complications include abscesses, meningoencephalitis, and implant-tissue margin infections. Antimicrobial overuse has increased bacterial resistance, risking macaque health and complicating treatment of infections. This project aimed to assess the antimicrobial effects of blue light (∼415 nm) and hypochlorous acid (HOCl) treatment of cranial implant margins. Blue light exerts antibacterial effects via the induction of reactive oxygen species. We hypothesized that exposing cranial implant margins to a commercially available blue light device followed by HOCl treatment would improve clinical appearance and decrease bacterial burden as assessed by aerobic/anaerobic culture and tissue margin microbiota analysis (decreased α and β diversity and altered taxonomic composition). Eight rhesus macaques were exposed to 6 min of blue light followed by 0.024% HOCl solution three times weekly for 4 wk. Swabs for microbiota analysis and bacterial cultures were collected before and 24 h after the last treatment session. Control microbiota swabs were collected from a separate implant margin area only exposed to HOCl. All animals tolerated the blue light exposure but had varied improvement in margin clinical appearance. The most common bacteria identified on culture were Staphylococcus aureus (n = 8), β-hemolytic streptococcus (n = 8), and Corynebacterium ulcerans (n = 6). Microbiota analysis of the 16S rRNA V4 gene region demonstrated many anaerobic operational taxonomic units in addition to the aerobic species cultured, highlighting limitations of culture-based methods. All animals had unique microbiota taxonomic profiles with a mean of 84 operational taxonomic units and a median Shannon diversity index of ∼2.6. No significant differences were found between treatment groups, α diversity, or β diversity before and after the study. The effectiveness of blue light therapy likely relates to the device power and depth of penetration into the tissue margin. While safe, future work is needed to optimize the dose and delivery methods of light-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.